Skip to main content
Environmental Health and Preventive Medicine logoLink to Environmental Health and Preventive Medicine
. 2003 May;8(2):37–40. doi: 10.1007/BF02897924

Animal model for oxidative stress research—Catalase mutant mice

Da-Hong Wang 1,, Noriyoshi Masuoka 2, Shohei Kira 1
PMCID: PMC2723317  PMID: 21432086

Abstract

Catalase-deficient mouse strains was initially established by Feinstein et al. through a large scale screening of the progeny of irradiated C3H mice in 1966. Later, Feinstein provided the mice of catalase mutant strain C3H/AnICsaCsa (wild-type), C3H/AnICsbCsb and C3H/AnlCscCsc to Okayama University Medical School in Japan. It is known that a point mutation at amino acid 11 (from glutamine to histidine) of acatalasemic mouse catalase and a point mutation at amino acid 439 (from as paragine to serine) of hypocatalasemic mouse catalase are responsible for the catalase deficiency of acatalasemic and hypocatalasemic mice, respectively. Recently, a liver cell line from an acatalasemic mouse andEscherichia coli (E. coli) strains with murine normal, hypocatalasemic, or acatalasemic catalase have been established. The construction of these new systems would be useful for studying the effects of oxidative stress at the cellular level. In this review, we give a brief overview of recent findings of studies in utilizing the catalase-deficient mice and evaluate the possibility of these mouse strains as a candidate animal model for oxidative stress research.

Key words: acatalasemia, catalase mutant mice, catalase activity, hydrogen peroxide, oxidative stress

References

  • (1).Scott MD, Lubin BH, Zuo L, Kuypers FA. Erythrocyte defense against hydrogen peroxide: preeminent importance of catalase. J. Lab. Clin. Med. 1991; 118: 7–16. [PubMed]
  • (2).Sun Y. Free radicals, antioxidant enzymes, and carcinogenesis. Free Radic. Biol. Med. 1990; 8: 583–599. [DOI] [PubMed]
  • (3).Aebi HE. Catalase. In: Bergmeyer HU, eds, Methods of enzymatic analysis, 3rd edn. Vol 7. VCH Verlagsgesellschatt mbH, 1985: 273–286.
  • (4).Takahara S, Miyamoto H. Clinical and experimental studies on the odontogenous progressive necrotic ostitis due to lack of blood catalase. J. Otorhinol. Soc. Jpn. 1948; 51: 163–164.
  • (5).Aebi HE, Wyss SR. Acatalasemia. In: Stanbury JB, Wyngaarden JB, Fredricson S, eds. 4th edn. The metabolic basis of inherited disease. New York: Megraw-Hill, 1978; 1792–1807.
  • (6).Goth L. Two cases of acatalasemic in Hungary. Clin. Chim. Acta 1992; 207: 155–158. [DOI] [PubMed]
  • (7).Ogata M. Acatalasemia. Hum. Genet. 1991; 86: 331–340. [DOI] [PubMed]
  • (8).Feinstein RN, Howard JB, Braun JT, Seaholm JE. Acatalasemic and hypocatalasemic mouse mutants. Genetics 1966; 53: 923–933. [DOI] [PMC free article] [PubMed]
  • (9).Feinstein RN, Braun JT, Howard JB. Acatalasemic and hypocatalasemic mouse mutants. Arch. Biochem. Biophys. 1967; 120: 165–169. [DOI] [PubMed]
  • (10).Tottori Y. Activity and stability of catalase in the organs of acatalasemic mice—Comparison of activities at different incubating temperatures by the perborate method. Okayama Igakkai Zasshi 1987; 99: 1623–1632 (in Japanese).
  • (11).Aebi H, Suter H, Feinstein RN. Activity and stability of catalase in blood and tissues of normal and acatalasemic mice. Biochem. Genet. 1968; 2: 245–251. [DOI] [PubMed]
  • (12).Wang DH, Tsutsui K, Sano K, Masuoka M, Kira S. cDNA cloning and expression of mutant catalase from the hypocatalasemic mouse: comparison with the acatalasemic mutant. Biochim. Biophys. Acta 2001; 1522: 217–220. [DOI] [PubMed]
  • (13).Ogata M, Kobayashi H, Ioku N, Ishii K. Methemoglobin concentration in the blood of acatalasemic mice. Proc. Jpn. Acad. 1986; 62: 360–371.
  • (14).Masuoka N, Wakimoto M, Ubuka T, Nakano T. Spectrophotometric determination of hydrogen peroxide: catalase activity and rates of hydrogen peroxide removal by erythrocytes. Clinica. Chimica. Acta 1996; 254: 101–112. [DOI] [PubMed]
  • (15).Karinje KU, Ogata M. Methanol metabolism in acatalasemic mice. Physiol. Chem. Phys. Med. NMR 1990; 22: 193–198. [PubMed]
  • (16).Ogata M, Aikoh H. The oxidation of metallic mercury by catalase in relation to acatalasemia. Industrial Health 1983; 21: 219–230. [DOI] [PubMed]
  • (17).Wang DH, Ishii K, Zhen LX, Taketa K. Enhanced liver injury in acatalasemic mice following exposure to carbon tetrachloride. Arch. Toxicol. 1996; 70: 189–194. [DOI] [PubMed]
  • (18).Wang DH, Ishii K, Taketa K. Inhibition of carbon tetrachloride-induced liver injury in acatalasemic mice by hepatic iron deprivation. Hepatol. Res. 1998; 10: 237–247. [DOI]
  • (19).Ogata M, Ishii K, Ioku N, Meguro T. Methemoglobin formation in the blood of Japanese subjects and mice suffering from acatalasemia in response to methemoglobin inducers. Physiol. Chem. Phys. Med. NMR 1990; 22: 125–134. [PubMed]
  • (20).Zhen LX, Ishii K, Taketa K, Ogata M. Inhibitory effect of α-tocopherol on methemoglobin formation by nitric oxide in normal and acatalasemic mouse hemolysates. Physiol. Chem. Phys. & Med. NMR 1993; 25:253–260. [PubMed]
  • (21).Yamaoka K, Nomura T, Wang DH, Mori S, Taguchi T, Ishikawa T, Hanamoto K, Kira S. Adjustment function among antioxidant substances in acatalasemic mouse brain and its enhancement by low-dose X-ray irradiation. Physiol. Chem. Phys. & Med. NMR (in press). [PubMed]
  • (22).Quintiliani M. The oxygen effect in radiation inactivation of DNA and enzymes. Int J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 1986; 50: 573–594. [DOI] [PubMed]
  • (23).Ishii K, Zhen LX, Wang DH, Taketa K. Prevention of mammary tumorenesis in acatalasemic mice by vitamin E supplementation. Jpn. J. Cancer Res. 1996; 87: 680–684. [DOI] [PMC free article] [PubMed]
  • (24).Wang DH, Funamori Y, Ikeda S, Sato M, Kira S, Taketa K. Enhanced hepatocarcinogenesis in acatalasemic mice treated with Diethylnitrosamine. Hepatol. Res. 1998; 12: 217–224. [DOI]
  • (25).Reddy JK, Rao S, Moody DE. Hepatocellular carcinomas in acatalasemic mice treated with nafenopin, a hypolipidemic peroxisome proliferator. Cancer Res. 1976; 36: 1211–1217. [PubMed]
  • (26).Shaffer JB, Preston KE. Molecular analysis of an acatalasemic mouse mutant. Biochem. Biophys. Res. Comm. 1990; 173: 1043–1050. [DOI] [PubMed]
  • (27).Wen JK, Osumi T, Hashimoto T, Ogata M. Molecular analysis of human acatalasemia: Identification of splicing mutation. J. Mol. Biol. 1990; 211: 383–393. [DOI] [PubMed]
  • (28).Zeiger E. Identification of rodent carcinogens and noncarcinogens using genetic toxicity tests: premises, promises, and performance. Reful. Toxicol. Pharmacol. 1998; 28: 85–95. [DOI] [PubMed]
  • (29).Boveris A, Chance B. The mitochondrial generation hydrogen peroxide. Biochem. J. 1973; 134: 707–716. [DOI] [PMC free article] [PubMed]
  • (30).Kawanishi S, Hiraku Y, Murata M, Oikawa S. The role of metals in site-specific DNA damage with reference to carcinogenesis. Free Radic. Biol. Med. 2002; 8: 583–599. [DOI] [PubMed]
  • (31).Lindau-Shepard BA, Shaffer JB. Expression of human catalase in acatalasemic murine SV-B2 cells confers protection from oxidative damage. Free Radic. Biol. Med. 1993; 15: 581–588. [DOI] [PubMed]
  • (32).Kondo A, Miyazaki M, Pu H, Gao C, Namba M. Establishment and cellular characteristics of a hepatocyte cell line (OUMS-31) derived from an acatalasemic mouse. In Vitro. Cell. Dev. Biol. Anim. 1999; 35: 155–158. [DOI] [PubMed]

Articles from Environmental Health and Preventive Medicine are provided here courtesy of The Japanese Society for Hygiene

RESOURCES